d565
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 17, 2017 (NCT03034486)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- d565
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05207761 | Phase 1 | Jan 19, 2022 | Chong Kun Dang Pharmaceutical |
| NCT03034486 | Phase 1 | Feb 17, 2017 | Chong Kun Dang Pharmaceutical, Dong-A University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chong Kun Dang Pharmaceutical | For profit | 2 | 2 | 1 | 2017 |
| Dong-A University | Academic/Hospital | 1 | 0 | 1 | 2017 |
2 organizations
Page 1 / 1